tiprankstipranks
Advertisement
Advertisement
CVRx reports Q1 EPS (50c), consensus (50c)
PremiumThe FlyCVRx reports Q1 EPS (50c), consensus (50c)
1M ago
CVRx backs FY26 revenue view $63M-$67M, consensus $64.99M
Premium
The Fly
CVRx backs FY26 revenue view $63M-$67M, consensus $64.99M
1M ago
CVRx sees Q2 revenue $15.1M-$16.1M, consensus $15.6M
Premium
The Fly
CVRx sees Q2 revenue $15.1M-$16.1M, consensus $15.6M
1M ago
CVRx’s BENEFIT-HF Trial: New Heart Failure Study Sets Up a Key Catalyst for Investors
PremiumCompany AnnouncementsCVRx’s BENEFIT-HF Trial: New Heart Failure Study Sets Up a Key Catalyst for Investors
3M ago
CVRx management to meet virtually with Lake Street
Premium
The Fly
CVRx management to meet virtually with Lake Street
3M ago
CVRx Introduces New Performance-Based Executive Stock Unit Plan
Premium
Company Announcements
CVRx Introduces New Performance-Based Executive Stock Unit Plan
4M ago
CVRx sees Q1 revenue $13.7M-$14.7M, consensus $14.1M
PremiumThe FlyCVRx sees Q1 revenue $13.7M-$14.7M, consensus $14.1M
4M ago
CVRx sees FY26 revenue $63M-$67M, consensus $64.72M
Premium
The Fly
CVRx sees FY26 revenue $63M-$67M, consensus $64.72M
4M ago
CVRx initiates BENEFIT-HF clinical trial
Premium
The Fly
CVRx initiates BENEFIT-HF clinical trial
5M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100